UB Paderborn / Katalog / Suche / in CDI

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer

Oncogene, 2014-08, Vol.33 (34), p.4307-4315

2014

Volltextzugriff (PDF)

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications

Annals of oncology, 2014-06, Vol.25 (6), p.1184-1192

2014

Volltextzugriff (PDF)

p53 Deficiency Does not Affect the Accumulation of Point Mutations in a Transgene Target

Proceedings of the National Academy of Sciences - PNAS, 1995-08, Vol.92 (18), p.8517-8521

1995

Volltextzugriff (PDF)

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products

Cancer research (Chicago, Ill.), 2005-07, Vol.65 (14), p.6189-6198

2005

Volltextzugriff (PDF)

Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity

The Journal of biological chemistry, 2004-04, Vol.279 (18), p.19191-19200

2004

Volltextzugriff (PDF)

Integrating microRNA and mRNA expression profiling using a novel algorithm identified a small set of unique genes upregulated in malignant pleural mesothelioma (MPM)

Journal of clinical oncology, 2009-05, Vol.27 (15_suppl), p.e22111-e22111

2009

Volltextzugriff (PDF)

High expression of epithelial-mesenchymal transition (EMT) markers in malignant mesothelioma and possible therapeutic intervention using an N-cadherin antagonist

Journal of clinical oncology, 2008-05, Vol.26 (15_suppl), p.8067-8067

2008

Volltextzugriff (PDF)

Genetics Targeting sheep

Nature (London), 2000-06, Vol.405 (6790), p.1004-1005

2000

Volltextzugriff (PDF)

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Nature communications, 2014-10, Vol.5 (1), p.5241-5241, Article 5241

2014

Volltextzugriff (PDF)

Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features

Clinical cancer research, 2010-07, Vol.16 (14), p.3743-3753

2010

Volltextzugriff (PDF)

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

The Journal of clinical investigation, 2018-04, Vol.128 (4), p.1267-1282

2018

Volltextzugriff (PDF)

High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation

Journal of thoracic oncology, 2012-05, Vol.7 (5), p.833-840

2012

Volltextzugriff (PDF)

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

The Journal of clinical investigation, 2018-07, Vol.128 (7), p.3198-3198

2018

Volltextzugriff (PDF)

Abstract 4643: EZH2 promote a malignant phenotype in lung adenocarcinoma and VEGF/VEGFR2 pathways mediates regulation of EZH2 through E2F3/HIF-1α and downregulation of miR-101

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.4643-4643

2013

Volltextzugriff (PDF)

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

BMC genomics, 2015-10, Vol.16 (1), p.752-752, Article 752

2015

Volltextzugriff (PDF)

Immunohistochemical Overexpression of Platelet-Derived Growth Factor Receptor–Beta (PDGFR-β) is Associated With PDGFRB Gene Copy Number Gain in Sarcomatoid Non–Small-Cell Lung Cancer

Clinical lung cancer, 2011-11, Vol.12 (6), p.369-374

2011

Volltextzugriff (PDF)

Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.8063-8063

2014

Volltextzugriff (PDF)

Abstract 1714: EZH2Hig h and miR-101Lo w expressions are associated with chemoresistance and shorter survival in patients with lung adenocarcinoma who received adjuvant chemotherapy

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1714-1714

2012

Volltextzugriff (PDF)

Abstract 5166: Identification of prostate stem cell antigen (PSCA) as a potential marker for lung cancer brain metastasis

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.5166-5166

2011

Volltextzugriff (PDF)

Abstract 4121: Folate pathway in malignant pleural mesothelioma (MPM): Novel therapeutic opportunities due to folate receptor alpha overexpression

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4121-4121

2011

Volltextzugriff (PDF)

Abstract 4031: CNG c-myc in mesothelioma

Cancer research (Chicago, Ill.), 2011-04, Vol.71 (8_Supplement), p.4031-4031

2011

Volltextzugriff (PDF)

High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation

Journal of thoracic oncology, 2012-05, Vol.7 (5), p.833-840

2012

Volltextzugriff (PDF)

Glycogen Synthase Kinase-3Î² Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity

The Journal of biological chemistry, 2004-04, Vol.279 (18), p.19191

2004

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

miR-93-directed downregulation of DAB2 defines a novel oncogenic pathway in lung cancer

Expression profiling stratifies mesothelioma tumors and signifies deregulation of spindle checkpoint pathway and microtubule network with therapeutic implications

p53 Deficiency Does not Affect the Accumulation of Point Mutations in a Transgene Target

Suppression of prostate tumor cell growth by stromal cell prostaglandin D synthase-derived products

Glycogen synthase kinase-3 beta is involved in the phosphorylation and suppression of androgen receptor activity

Integrating microRNA and mRNA expression profiling using a novel algorithm identified a small set of unique genes upregulated in malignant pleural mesothelioma (MPM)

High expression of epithelial-mesenchymal transition (EMT) markers in malignant mesothelioma and possible therapeutic intervention using an N-cadherin antagonist

Genetics Targeting sheep

Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression

Nrf2 and Keap1 Abnormalities in Non-Small Cell Lung Carcinoma and Association with Clinicopathologic Features

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

High Expression of Folate Receptor Alpha in Lung Cancer Correlates with Adenocarcinoma Histology and Mutation

The epithelial-to-mesenchymal transition activator ZEB1 initiates a prometastatic competing endogenous RNA network

Abstract 4643: EZH2 promote a malignant phenotype in lung adenocarcinoma and VEGF/VEGFR2 pathways mediates regulation of EZH2 through E2F3/HIF-1α and downregulation of miR-101

Combined clinical and genomic signatures for the prognosis of early stage non-small cell lung cancer based on gene copy number alterations

Immunohistochemical Overexpression of Platelet-Derived Growth Factor Receptor–Beta (PDGFR-β) is Associated With PDGFRB Gene Copy Number Gain in Sarcomatoid Non–Small-Cell Lung Cancer

Regulation of tumor cell PD-L1 expression by microRNA-200 and control of lung cancer metastasis

Abstract 1714: EZH2Hig h and miR-101Lo w expressions are associated with chemoresistance and shorter survival in patients with lung adenocarcinoma who received adjuvant chemotherapy

Abstract 5166: Identification of prostate stem cell antigen (PSCA) as a potential marker for lung cancer brain metastasis

Abstract 4121: Folate pathway in malignant pleural mesothelioma (MPM): Novel therapeutic opportunities due to folate receptor alpha overexpression

Abstract 4031: CNG c-myc in mesothelioma

High expression of folate receptor alpha in lung cancer correlates with adenocarcinoma histology and EGFR [corrected] mutation

Glycogen Synthase Kinase-3Î² Is Involved in the Phosphorylation and Suppression of Androgen Receptor Activity

Suchergebnisse filtern